Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
indiana blog main
indiana top stories
6
×
life sciences
national blog main
national top stories
roche
6
×
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
novartis
president trump
cancer immunotherapy
clinical trials
deals
investing
medicare
merck
pfizer
startups
alexion pharmaceuticals
What
drug
6
×
roundup
bio
cancer
fda
genetic
latest
new
patients
plan
today
acquisitions
address
advantages
ahead
albert
alzheimer’s
ambien
american
annual
approval
approved
approves
asco
attendees
attention
bar
biggest
biotech
blueprint
bourla
brings
camp’s
carries
cash
ceo
certain
chicago
city
clinical
Language
unset
unknown
Current search:
roche
×
drug
×
" indiana top stories "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More